Carregant...
Spasticity and Its Contribution to Hypertonia in Cerebral Palsy
Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...
Guardat en:
| Publicat a: | Biomed Res Int |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi Publishing Corporation
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/ https://ncbi.nlm.nih.gov/pubmed/25649546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|